Literature DB >> 192829

Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.

G Miller, T Shope, D Coope, L Waters, J Pagano, G Bornkamn, W Henle.   

Abstract

6 of 20 cotton-top tamarins (Saguinus oedipus) inoculated with Epstein-Barr virus (EBV) developed diffuse malignant lymphoma resembling reticulum cell or immunoblastic sarcoma of man. Hyperplastic lymphoreticular lesions were induced in three additional animals; in two instances the hyperplastic lesions regressed. Inapparent infection with development of antibody occured in eight animals. In two animals there was no evidence of EBV infection. One animal died in the first week after inoculation of parasitic infection. 10 animals uninoculated or mock-inoculated developed neither lymphoproliferative disease nor antibody. The malignant lymphoma appeared to arise from a cell with an uncleaved vesicular nucleus found in the center of the germinal follicle. The prominent cytologic features of this cell were extensive formation or rough endoplasmic reticulum and elaboration of the cytoplasmic membrane with microvilli. Cell lines derived from these tumors did not have receptors for complement. IgFc, or sheep erythrocytes, and the cell lines adhered to glass and plastic. EB nuclear antigen was found in imprints of two lymph nodes, one with lymphoma and one with hyperplasia. EB virus DNA was detected directly in the tumors of three animals and in cell lines from two lymphomas. Typical herpes virus particles were found in supernatant fluids from cell lines obtained from lymph nodes with tumors and hyperplasia, as well as in lines derived from blood leukocytes of marmosets with inapparent infection. These virus preparations had the biologic property characteristic of EBV, namely, stimulation of cellular DNA synthesis and immortalization of human lymphocytes. The virus derived from two cell lines was neutralized by reference human sera with EBV antibody and not by antibody-negative human sera. The virus derived from the experimental lesions is thus indistinghishable from human EBV. The marmoset has enhanced susceptibility to oncogenesis by EB virus. Among identified factors which may play a role in the heightened tumorigenicity of EB virus in this species are the increased production of virus by transformed cells and the absence of membrane receptors for complement or IgFc on transformed cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192829      PMCID: PMC2180630          DOI: 10.1084/jem.145.4.948

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets.

Authors:  H Wolf; J Werner; H zur Hausen
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Immortalizing and nonimmortalizing laboratory strains of Epstein-Barr Virus.

Authors:  G Miller; J Robinson; L Heston
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). III. Serological and biochemical findings in an animal with reticuloproliferative disease.

Authors:  M A Epstein; H zur Hausen; G Ball; H Rabin
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

4.  Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus.

Authors:  J Werner; H Wolf; J Apodaca; H zur Hausen
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

5.  DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness.

Authors:  R F Pritchett; S D Hayward; E D Kieff
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

6.  Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.

Authors:  J Robinson
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

7.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

8.  Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis.

Authors:  G W Bornkamm; H Stein; K Lennert; F Rüggeberg; H Bartels; H zur Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

9.  Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.

Authors:  G Miller; D Coope; J Niederman; J Pagano
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

10.  Direct visualization of enveloped Epstein-Barr Herpesvirus in throat washing with leukocyte-transforming activity.

Authors:  M Lipman; L Andrews; J Niederman; G Miller
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

View more
  35 in total

1.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

3.  Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs.

Authors:  H Delius; G W Bornkamm
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

Review 4.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.

Authors:  J I Cohen; F Wang; E Kieff
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.

Authors:  T Dambaugh; F Wang; K Hennessy; E Woodland; A Rickinson; E Kieff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  The resurgence and genetic implications of New World primates in biomedical research.

Authors:  Joshua M Ward; Eric J Vallender
Journal:  Trends Genet       Date:  2012-10-22       Impact factor: 11.639

8.  The cotton-top tamarin revisited: Mhc class I polymorphism of wild tamarins, and polymorphism and allelic diversity of the class II DQA1, DQB1, and DRB loci.

Authors:  U Gyllensten; T Bergström; A Josefsson; M Sundvall; A Savage; E S Blumer; L H Giraldo; L H Soto; D I Watkins
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Transmission of naturally occurring lymphoma in macaque monkeys.

Authors:  R D Hunt; B J Blake; L V Chalifoux; P K Sehgal; N W King; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Unusually limited nucleotide sequence variation of the expressed major histocompatibility complex class I genes of a New World primate species (Saguinus oedipus).

Authors:  D I Watkins; T L Garber; Z W Chen; G Toukatly; A L Hughes; N L Letvin
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.